| Serial Number | 79411970 |
| Word Mark | DISCO PHARMACEUTICALS |
| Filing Date | Thursday, June 13, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, August 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized wording "DISCO" where the letter "D" appears in blue, the letter "I" in red, the letter "S" in orange, the letter "C" in green and the letter "O" is a shaded blue circle with a disco ball design located on the inside of the shaded circle that has a yellow outline and squares in yellow, orange, and green color inside the disco ball. Underneath the word "DISCO" appears the wording "PHARMACEUTICALS" in green stylized font. |
| Goods and Services | Chemical preparations for medical use, namely, for treating neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; pharmaceutical preparations for the prevention and treatment of neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; immunostimulatory compositions being pharmaceutical preparations for the prevention and treatment of neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; vaccines; adjuvant immunostimulants, namely, adjuvants for medical purposes; pharmaceuticals and medicines based on biological micromolecules for treating neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; pharmaceuticals and medicines, namely, enzymes and proteins for medical use in protein and enzyme replacement therapy; Pharmaceutical preparations for gene therapy for the treatment of neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; all of the foregoing excluding nutritional supplements, phytotherapy preparations for medical purposes, and products for biomedical research and testing |
| Goods and Services | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating neurological, neuromuscular, neurodegenerative, cardiovascular diseases, infectious diseases, allergies, autoimmune disorders, tumours, metabolic disorders, and inherited genetic diseases; biomolecules, in particular biological macromolecules, namely, proteins for use in the manufacture of pharmaceuticals; all the foregoing for scientific and industrial purposes for the human pharmaceutical industry and excluding products for biomedical research and testing. |
| Goods and Services | Medical services, in particular for therapeutic and preventative treatment of tumours, infectious diseases, autoimmune disorders and allergies, for treating inherited genetic diseases and for protein and enzyme replacement therapy, and for treating neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treating metabolic disorders |
| NOT AVAILABLE | PHARMACEUTICALS |
| Goods and Services | Scientific and technological services and research services, in particular for identifying and characterizing biological macromolecules, namely, biological and chemical research and analysis; development of pharmaceuticals preparations or vaccines; conducting of and scientific support for preclinical or clinical studies, namely, scientific research in the nature of conducting pre-clinical and clinical trials for others; all of the foregoing excluding products for biomedical research and testing |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DISCO Pharmaceuticals GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, December 12, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 13, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 18, 2024 | ASSIGNED TO EXAMINER |
| Saturday, December 21, 2024 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Monday, December 30, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 5, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, February 22, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, June 25, 2025 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Tuesday, August 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 5, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 5, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 27, 2025 | ATTORNEY REVIEW COMPLETED |
| Friday, December 13, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, December 31, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, February 5, 2025 | REFUSAL PROCESSED BY MPU |